Molecular regulation of the renin–angiotensin system by sodium–glucose cotransporter 2 inhibition in type 1 diabetes mellitus
Chantal Kopecky(UNSW Sydney), Marcus D. Säemann(Universitätszahnklinik Wien), Kerry‐Anne Rye(Royal Adelaide Hospital), Christopher C. Kaltenecker(Medical University of Vienna), Marlies Antlanger(Medical University of Vienna), Marko Poglitsch, Yuliya Lytvyn(University Health Network), Oliver Domenig(Medical University of Vienna), Bruce A. Perkins(Sinai Health System), J Kovarík(Medical University of Vienna), David Z.I. Cherney(University Health Network)
Cited by 23
Related Papers
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
|The Lancet|2022|1k
Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions
|American Journal of Transplantation|2014|522
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
|Circulation|2017|470
A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection
|Journal of the American Society of Nephrology|2017|302
Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4–dependent mechanism
|Journal of Clinical Investigation|2005|222